RDHL Stock Recent News

Can these penny stocks trading tips help your strategy? The post 3 Strategies for Buying and Selling Penny Stocks Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Redhill Biopharma (NASDAQ: RDHL ) stock is rocketing higher on Wednesday after the company received a patent for one of its oral antiviral treatments. That patent covers the administration of opaganib.

RedHill's (RDHL) RHB-204 gets Orphan Drug designation from the European Commission for the treatment of nontuberculous mycobacteria (NTM) disease

Here's what you need to know about trading penny stocks on July 12th The post What to Know About Buying Penny Stocks on July 12th appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Can these penny stocks make gains this coming week? The post Hot Penny Stocks to Buy Right Now?

RedHill Biopharma Ltd. (NASDAQ:RDHL ) Q1 2022 Results Conference Call June 23, 2022 8:30 AM ET Company Participants Debbie Bechor - Business Development & Communications Manager Dror Ben-Asher - Chief Executive Officer Rick Scruggs - President and Chief Commercial Officer Guy Goldberg - Chief Business Officer Gilead Raday - Chief Operating Officer Micha Ben-Chorin - Chief Financial Officer Adi Frish - Chief Corporate and Business Development Officer Rob Jackson - Senior Vice President of Marketing Conference Call Participants Brandon Folkes - Cantor Fitzgerald Boobalan Pachaiyappan - H.C.

RedHill Biopharma Ltd (NASDAQ: RDHL) plans announced a cost reduction plan expected to generate operational cost savings of approximately $50 million over the next 18 months. Most of these savings result from an approximately one-third reduction of the U.S. commercial team workforce,.

TEL AVIV, Israel and RALEIGH, N.C. , June 17, 2022 /PRNewswire/ -- RedHill Biopharma Ltd.